179 related articles for article (PubMed ID: 7687721)
61. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.
McCullough JR; Normandin DE; Conder ML; Sleph PG; Dzwonczyk S; Grover GJ
Circ Res; 1991 Oct; 69(4):949-58. PubMed ID: 1934346
[TBL] [Abstract][Full Text] [Related]
62. A comparison of the actions of cromakalim and nifedipine on rabbit isolated mesenteric artery.
McHarg AD; Southerton JS; Weston AH
Eur J Pharmacol; 1990 Aug; 185(2-3):137-46. PubMed ID: 2123796
[TBL] [Abstract][Full Text] [Related]
63. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
Kreye VA; Lenz T; Pfründer D; Theiss U
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
[TBL] [Abstract][Full Text] [Related]
64. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
Tamura K; Suzuki Y; Yoshida S; Nabata H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750
[TBL] [Abstract][Full Text] [Related]
65. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
Kwan YW; To KW; Lau WM; Tsang SH
Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
[TBL] [Abstract][Full Text] [Related]
66. The ginsenoside Rg3 evokes endothelium-independent relaxation in rat aortic rings: role of K+ channels.
Kim ND; Kang SY; Kim MJ; Park JH; Schini-Kerth VB
Eur J Pharmacol; 1999 Feb; 367(1):51-7. PubMed ID: 10082264
[TBL] [Abstract][Full Text] [Related]
67. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
[TBL] [Abstract][Full Text] [Related]
68. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
Eltze M
Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
[TBL] [Abstract][Full Text] [Related]
69. [Effects of resveratrol on isolated thoracic aorta rings of rats].
Zhang HY; Xu CQ; Li HZ; Li BX; Zhang YQ; Zhang YN
Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1283-6. PubMed ID: 16245911
[TBL] [Abstract][Full Text] [Related]
70. Effects of BRL 38227 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery.
Russell SN; Smirnov SV; Aaronson PI
Br J Pharmacol; 1992 Mar; 105(3):549-56. PubMed ID: 1628142
[TBL] [Abstract][Full Text] [Related]
71. Evidence that imidazol(id)ine- and sulphonylurea-based antagonists of cromakalim act at different sites in the rat thoracic aorta.
Challinor JL; McPherson GA
Clin Exp Pharmacol Physiol; 1993; 20(7-8):467-75. PubMed ID: 8403526
[TBL] [Abstract][Full Text] [Related]
72. RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine.
Raeburn D; Brown TJ
J Pharmacol Exp Ther; 1991 Feb; 256(2):480-5. PubMed ID: 1899701
[TBL] [Abstract][Full Text] [Related]
73. Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery.
Eckman DM; Frankovich JD; Keef KD
Br J Pharmacol; 1992 May; 106(1):9-16. PubMed ID: 1504734
[TBL] [Abstract][Full Text] [Related]
74. Possible mechanism of the potent vasoconstrictor responses to ryanodine in dog cerebral arteries.
Asano M; Kuwako M; Nomura Y; Suzuki Y; Shibuya M; Sugita K; Ito K
Eur J Pharmacol; 1996 Sep; 311(1):53-60. PubMed ID: 8884236
[TBL] [Abstract][Full Text] [Related]
75. Mechanisms of vasorelaxation induced by N-allylsecoboldine in rat thoracic aorta.
Yu SM; Lee SS; Hou YS; Teng CM
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):637-43. PubMed ID: 7969515
[TBL] [Abstract][Full Text] [Related]
76. A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim.
Gelband CH; Lodge NJ; Van Breemen C
Eur J Pharmacol; 1989 Aug; 167(2):201-10. PubMed ID: 2591475
[TBL] [Abstract][Full Text] [Related]
77. Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery.
Bray K; Quast U
Br J Pharmacol; 1991 Mar; 102(3):585-94. PubMed ID: 1285396
[TBL] [Abstract][Full Text] [Related]
78. Effects of potassium channel modulators cromakalim, tetraethylammonium and glibenclamide on the contractility of the isolated human ureter.
de Moura RS; de Lemos Neto M
J Urol; 1996 Jul; 156(1):276-80. PubMed ID: 8648822
[TBL] [Abstract][Full Text] [Related]
79. Hypoglycemic sulfonylureas antagonize the effects of cromakalim and pinacidil on 86Rb fluxes and contractile activity in the rat aorta.
Lebrun P; Fang ZY; Antoine MH; Herchuelz A; Hermann M; Berkenboom G; Fontaine J
Pharmacology; 1990; 41(1):36-48. PubMed ID: 2122482
[TBL] [Abstract][Full Text] [Related]
80. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
Lodge NJ; Halaka NN
J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
